We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Sansure Biotech Inc

Sansure Biotech is an integrated solutions manufacturer and provider of diagnostic reagents, nucleic acid diagnostic ... read more Featured Products: More products

Download Mobile App





Sansure Biotech Demonstrates iPonatic III Portable Molecular Workstation

By LabMedica International staff writers
Posted on 24 May 2023

Sansure Biotech (Hunan, China) is demonstrating its comprehensive range of IVD solutions at EuroMedLab Rome 2023, including the iPonatic III portable molecular workstation. More...

As a bronze sponsor of the Congress, Sansure is welcoming visitors to its booth where the company’s technicians are showcasing the operations of the iPonatic III portable molecular workstation and presenting its key features and applications. The portable molecular workstation stands out for its ability to deliver extremely accurate test results within 8 to 45 minutes. Equipped with innovative one-tube fast release and rapid PCR amplification technology, it enhances point of care testing (POCT) by optimizing steps such as sample handling, nucleic acid extraction, purification, PCR amplification, and result processing. In addition, the iPonatic III offers a versatile and expandable testing menu, capable of catering to the testing requirements of various pathogens. Its adaptability and portability make it useful in numerous settings, ranging from medical laboratories to emergency rooms. The ultimate objective of this device is to facilitate lab-standard molecular diagnostic services at point-of-care facilities like doctor's offices, clinics, and pharmacies, thereby providing critical support to global healthcare communities.

Among Sansure’s latest developments in the field of diagnostics being presented at the industry event is the newly-launched Natch 16S nucleic acid extraction system. Natch 16S employs magnetic bead technology and boasts ten different mixing modes. It incorporates a built-in UV lamp and air filtration system, touch control, and a 7-inch touchscreen. With the capacity to extract nucleic acid in 10-60 minutes per batch, the Natch 16S finds applications across numerous fields, including sexually transmitted diseases, women's health, respiratory diseases, gastrointestinal diseases, prenatal and postnatal care, and public health.

Related Links:
Sansure Biotech


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.